Company announcements: Healthway, Biosensors, China XLX, China Great

Healthway - ANNOUNCEMENT OF APPOINTMENT OF INDEPENDENT DIRECTOR WHO IS AN AUDIT COMMITTEE MEMBER

Announcement Type: ANNOUNCEMENT OF APPOINTMENT
Company: HEALTHWAY MEDICAL CORP LTD
Stock Code/Name: 5NG - Healthway

ANNOUNCEMENT OF APPOINTMENT OF INDEPENDENT DIRECTOR WHO IS AN AUDIT COMMITTEE MEMBER * Asterisks denote mandatory information Name of Announcer * HEALTHWAY MEDICAL CORP LTD Company Registration No. 200708625C Announcement submitted on behalf of HEALTHWAY MEDICAL CORP LTD Announcement is submitted with respect to * HEALTHWAY MEDICAL CORP LTD Announcement is submitted by * Fan Kow Hin Designation * Executive Chairman Date & Time of Broadcast 10-Mar-2014 17:54:04 Announcement No. 00081   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Date of Appointment * 10/03/2014 Name of person * Sonny Yuen Chee Choong Age * 53 Country of principal residence * Singapore The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) * Upon the recommendation of the Nominating Committee, which had reviewed the qualifications and experience of Sonny Yuen Chee Choong ("Mr Yuen"), the Board of Directors approved his appointment as an Independent Director of the Company. The Board considers Mr Yuen to be independent for the purposes of Rule 704(7) of the Listing Manual Section B: Rules of Catalist of the Singapore Exchange Securities Trading Limited. Whether appointment is executive, and if so, the area of responsibility * No Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Independent Director, Audit Committee Member and Nominating Commitee Member Working experience and occupation(s) during the past 10 years * Managing Director, JonDavidson Pte Ltd from June 2007 to present Senior Consultant, Executive Network International Pte Ltd from November 2006 to May 2007 Director, Libra 2002 Pte Limited from January 2004 to August 2006 Interest * in the listed issuer and its subsidiaries * Nil Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries * Nil Conflict of interests (including any competing business) * Nil   >> OTHER DIRECTORSHIP # These fields are not applicable for announcements of appointments pursuant to Listing Rule 704(9) or Catalist Rule 704(8). Past (for the last 5 years) JonDavidson Healthcare Pte Ltd Medical Partners Pte Ltd Present JonDavidson Pte Ltd Asia Pacific Pathfinder Pte Ltd   >> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(H) Disclose the following matters concerning an appointment of director, chief executive officer, general manager or other executive officer of equivalent rank. If the answer to any questions is "yes", full details must be given. (a)* Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? No (b)* Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? No (c)* Whether there is any unsatisfied judgment against him? No (d)* Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? No (e)* Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? No (f)* Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? No (g)* Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? No (h)* Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? No (i)* Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? No (j)* Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :- (i)* any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or No (ii)* any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or No (iii)* any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or No (iv)* any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? No (k)* Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? No   >> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(I) Disclosure applicable to the appointment of Director only. Any prior experience as a director of a listed company? No If no, please provide details of any training undertaken in the roles and responsibilities of a director of a listed company. The Company will arrange for Mr Yuen to attend relevant training to familiarise himself with the roles and responsibilities of a director of a public listed company, including seminar conducted by the Singapore Institute of Directors. Footnotes This announcement has been prepared by Healthway Medical Corporation Limited (the Company) and its contents have been reviewed by PrimePartners Corporate Finance Pte. Ltd. (the Sponsor), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the SGX-ST). The Sponsor has not independently verified the contents of this announcement. This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Mr Mark Liew, Managing Director, Corporate Finance, at 20 Cecil Street, #21-02 Equity Plaza, Singapore 049705, telephone (65) 6229 8088. Attachments Total size = 0K (2048K size limit recommended)

---

Healthway - ANNOUNCEMENT OF APPOINTMENT OF EXECUTIVE DIRECTOR

Announcement Type: ANNOUNCEMENT OF APPOINTMENT
Company: HEALTHWAY MEDICAL CORP LTD
Stock Code/Name: 5NG - Healthway

ANNOUNCEMENT OF APPOINTMENT OF EXECUTIVE DIRECTOR * Asterisks denote mandatory information Name of Announcer * HEALTHWAY MEDICAL CORP LTD Company Registration No. 200708625C Announcement submitted on behalf of HEALTHWAY MEDICAL CORP LTD Announcement is submitted with respect to * HEALTHWAY MEDICAL CORP LTD Announcement is submitted by * Fan Kow Hin Designation * Executive Chairman Date & Time of Broadcast 10-Mar-2014 17:48:42 Announcement No. 00075   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Date of Appointment * 10/03/2014 Name of person * Yeow Ming Ying Age * 57 Country of principal residence * Singapore The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) * Upon the recommendation of the Nominating Committee, which had reviewed the qualifications and experience of Yeow Ming Ying ("Mr Yeow"), the Board of Directors approved his appointment as an Executive Director of the Healthway Medical Corporation Limited (the "Company" or "HMC"). Whether appointment is executive, and if so, the area of responsibility * Executive appointment; Responsible for overseeing the medical practice groups of the Primary Healthcare, Specialist Healthcare and Wellness divisions in Singapore Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) President, Medical Services Singapore and Executive Director Working experience and occupation(s) during the past 10 years * President, Medical Services Singapore , HMC from December 2012 to present General Manager, HMC from June 2012 to December 2012 Managing Director (South East Asia, Sales & Services), GXS Inc from January 2004 to May 2009 Chief Executive Officer, EC1 Pte Ltd from January 1999 to January 2004 Interest * in the listed issuer and its subsidiaries * Nil Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries * No Conflict of interests (including any competing business) * No   >> OTHER DIRECTORSHIP # These fields are not applicable for announcements of appointments pursuant to Listing Rule 704(9) or Catalist Rule 704(8). Past (for the last 5 years) EC1 Pte Ltd Present Nil   >> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(H) Disclose the following matters concerning an appointment of director, chief executive officer, general manager or other executive officer of equivalent rank. If the answer to any questions is "yes", full details must be given. (a)* Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? No (b)* Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? No (c)* Whether there is any unsatisfied judgment against him? No (d)* Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? No (e)* Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? No (f)* Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? No (g)* Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? No (h)* Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? No (i)* Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? No (j)* Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :- (i)* any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or No (ii)* any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or No (iii)* any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or No (iv)* any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? No (k)* Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? No   >> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(I) Disclosure applicable to the appointment of Director only. Any prior experience as a director of a listed company? No If no, please provide details of any training undertaken in the roles and responsibilities of a director of a listed company. The Company will arrange for Mr Yeow to attend relevant training to familiarise himself with the roles and responsibilities of a director of a public listed company, including seminar conducted by the Singapore Institute of Directors. Footnotes Mr Yeow Ming Ying was involved in a traffic accident which caused injury in 2004. He was subsequently ordered to compensate the other party and the matter was closed in 2005. This announcement has been prepared by Healthway Medical Corporation Limited (the Company) and its contents have been reviewed by PrimePartners Corporate Finance Pte. Ltd. (the Sponsor), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the SGX-ST). The Sponsor has not independently verified the contents of this announcement. This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Mr Mark Liew, Managing Director, Corporate Finance, at 20 Cecil Street, #21-02 Equity Plaza, Singapore 049705, telephone (65) 6229 8088. Attachments Total size = 0K (2048K size limit recommended)

---

Biosensors - DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)

Announcement Type: DISCLOSURE OF INTEREST/CHANGES IN INTEREST
Company: BIOSENSORS INT'L GROUP, LTD.
Stock Code/Name: B20 - Biosensors

DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S) * Asterisks denote mandatory information Name of Announcer * BIOSENSORS INT'L GROUP, LTD. Company Registration No. EC 24983 Announcement submitted on behalf of BIOSENSORS INT'L GROUP, LTD. Announcement is submitted with respect to * BIOSENSORS INT'L GROUP, LTD. Announcement is submitted by * RONALD H. EDE Designation * CFO/ COMPANY SECRETARY Date & Time of Broadcast 10-Mar-2014 18:01:27 Announcement No. 00088   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Person(s) giving notice * Substantial Shareholder(s)/Unitholder(s) (Form 3) Date of receipt of notice by Listed Issuer * 10/03/2014 Attachments FORM3_CITICPE2_10MAR14.pdf Total size =233K (2048K size limit recommended)

---

China XLX - MISCELLANEOUS

Announcement Type: MISCELLANEOUS
Company: CHINA XLX FERTILISER LTD.
Stock Code/Name: B9R - China XLX

MISCELLANEOUS :: 1) POSSIBLE EXIT OFFER BY CITIC SECURITIES CORPORATE FINANCE (HK) LIMITED AND CLSA SINGAPORE PTE LTD FOR AND ON BEHALF OF THE POSSIBLE OFFEROR TO ACQUIRE ALL THE ISSUED ORDINARY SHARES IN THE CAPITAL OF THE COMPANY (OTHER THAN THOSE ALREADY OWNED, CONTROLLED OR AGREED TO BE ACQUIRED BY THE POSSIBLE OFFEROR AND PARTIES ACTING IN CONCERT WITH IT); AND 2) POSSIBLE DELISTING OF THE COMPANY FROM THE OFFICIAL LIST OF THE SGX-ST * Asterisks denote mandatory information Name of Announcer * CHINA XLX FERTILISER LTD. Company Registration No. 200610384G Announcement submitted on behalf of CHINA XLX FERTILISER LTD. Announcement is submitted with respect to * CHINA XLX FERTILISER LTD. Announcement is submitted by * Teo Meng Keong Designation * Company Secretary Date & Time of Broadcast 10-Mar-2014 17:33:56 Announcement No. 00059   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Announcement Title * 1) POSSIBLE EXIT OFFER BY CITIC SECURITIES CORPORATE FINANCE (HK) LIMITED AND CLSA SINGAPORE PTE LTD FOR AND ON BEHALF OF THE POSSIBLE OFFEROR TO ACQUIRE ALL THE ISSUED ORDINARY SHARES IN THE CAPITAL OF THE COMPANY (OTHER THAN THOSE ALREADY OWNED, CONTROLLED OR AGREED TO BE ACQUIRED BY THE POSSIBLE OFFEROR AND PARTIES ACTING IN CONCERT WITH IT); AND 2) POSSIBLE DELISTING OF THE COMPANY FROM THE OFFICIAL LIST OF THE SGX-ST Description Please refer to the attachment. Attachments China_XLX_monthly_updated_Mar2014.pdf Total size =77K (2048K size limit recommended)

---

China Great - MISCELLANEOUS :: RESULT OF EXTRAORDINARY GENERAL MEETING

Announcement Type: MISCELLANEOUS
Company: CHINA GREAT LAND HOLDINGS LTD.
Stock Code/Name: D50 - China Great

MISCELLANEOUS :: RESULT OF EXTRAORDINARY GENERAL MEETING * Asterisks denote mandatory information Name of Announcer * CHINA GREAT LAND HOLDINGS LTD. Company Registration No. 200312792W Announcement submitted on behalf of CHINA GREAT LAND HOLDINGS LTD. Announcement is submitted with respect to * CHINA GREAT LAND HOLDINGS LTD. Announcement is submitted by * LI ZHANGJIANG DE MALCA Designation * EXECUTIVE CHAIRMAN AND MANAGING DIRECTOR Date & Time of Broadcast 10-Mar-2014 17:33:36 Announcement No. 00058   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Announcement Title * RESULT OF EXTRAORDINARY GENERAL MEETING Description The Board of Directors of China Great Land Holdings Ltd. (the "Company") wishes to announce that at the Extraordinary General Meeting of the Company held on 10 March 2014 (the "EGM"), the resolution relating to the matter as set out in the Notice of EGM dated 21 February 2014 was duly passed. Attachments Total size = 0K (2048K size limit recommended)

---